Diagnostic Substances (Global) - Industry Report

  • ID: 1581133
  • October 2015
  • Region: Global
  • 110 pages
  • Plimsoll Publishing Ltd
1 of 3

The Diagnostic Substances (Global) Analysis provides a detailed overview of the Diagnostic Substances (Global) market and delivers a comprehensive individual analysis on the top 60 companies, including TAKEDA GMBH, MUNDIPHARMA GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG and MEDA MANUFACTURING GMBH.

This report includes a wealth of information on the financial trends over the past four years.

The latest Diagnostic Substances (Global) analysis is ideal for anyone wanting to:

- See the market leaders
- Identify companies heading for failure
- Seek out the most attractive acquisition
- Analyse industry trends
- Benchmark their own financial performance

Using The exclusive methodology, a quick glance of this Diagnostic Substances (Global) report will tell you that 8 companies have a declining financial rating, while 25 have shown good sales growth.

Each of the largest 60 companies is meticulously scrutinised in a two-page individual assessment and is analysed using the most up-to-date and current financial data.

Every business is examined on the following features:

- The Plimsoll Chart: A graphical assessment of a company’s financial performance

- Four year assessment of the profit/loss and balance sheet
- A written summary highlighting key performance issues

Subsequently, you will receive a thorough 100-page market analysis highlighting the latest changes in the Diagnostic Substances (Global) market.

This section includes:

- Best Trading Partners
- Sales Growth Analysis
- Profit Analysis
- Market Size
- Rankings

Note: Product cover images may vary from those shown
2 of 3

The Diagnostic Substances (Global) analysis is the most definitive and accurate study of the Diagnostic Substances (Global) sector in 2015.

The report is split into two sections and uses both a written and graphical analysis - analysing the 60 largest Diagnostic Substances (Global) companies.

The Diagnostic Substances (Global) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis.

Indeed, the first section thoroughly scrutinises the market and this section includes the following:

- Best Trading Partners: These are companies that are winning in both sales and financial strength - for example BAG HEALTH CARE GMBH has been ranked as a best trading partner in the industry.
- Sales Growth Analysis: This section reviews the fastest growing and fastest shrinking company - for example DAKO A/S is among the fastest growing.
- Profit Analysis - Analysis of gross profit and pre-tax profit over several years and a profitability summary comparing profits in the industry against small, medium and large companies.
- Market Size: Based on the largest 60 companies, this is a comparison between last year's market size and the most current figure (116.0 billion).
- Rankings: The top 50 companies ranked by: Market Share, Sales Growth, Gross Profit and Pre-tax Profit.

The next section focuses on company analysis and provides an in-depth analysis of the largest companies within the Diagnostic Substances (Global) industry.

Each business is analysed using an unequivocal model and culminates in the production of the "Plimsoll Chart". The Model uses a series of charts to graphically analyse an individual company and measure its ability to achieve sales growth while maintaining financial strength.

The "Plimsoll Chart" is a quick and dependable method of analysing a company’s financial well-being. It’s simple to understand: a rising line is good news and a falling line is bad news.

Therefore, this company analysis will tell you if a company is:

- Strong or heading for failure
- Utilising their investments
- Becoming burdened by debt
- Getting the most from their resources

The Diagnostic Substances (Global) analysis also provides you with full business name and address, names of directors and registration address.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: A printed copy of the report will be shipped to you.


If you have a more general question about our products please try our



Our Clients

  • bioCSL
  • Abbott Laboratories Ltd.
  • Radiometer Limited
  • Genfit
  • Focus Diagnostics Inc.
  • Genomic Health Inc.